Startups
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled resources are crucial for advancing products from development to commercial launch. Arranta Bio continues to expand capacity and development and manufacturing services across multiple sites with technology platforms designed to meet the evolving demands of our clients and partners.
Overview
Location
United States, Massachusetts, Watertown
Employees
51-200
Total raised
$82M
Founded date
2019
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 20, 2022 | From Fighting Shoplifting To Pioneering Gene Therapies, The Startups In This Accelerator Are On The Front Lines Of “Super Creativity” | When it comes to studying the nation’s shoplifting epidemic, Richelle Ross and Diego Rodriguez have a front-row seat. Working under the guidance of Read Hayes, a research scientist and criminologist at University of Florida, they are part o... |
| Apr 11, 2022 | Recipharm completes US biologics acquisitions | Recipharm completes US biologics acquisitions Mon, Apr 11, 2022 07:00 CET Report this content Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advance... |
| Feb 18, 2022 | Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US | Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to expand its biologics offering in the US Fri, Feb 18, 2022 08:00 CET Report this content Recipharm, a leading global contract development and ma... |
| Oct 27, 2021 | Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio To Accelerate Cell Therapies To Cure Cancer | RALEIGH, N.C., Oct. 27, 2021 /PRNewswire/ -- Inceptor Bio ("Inceptor"), today announced an agreement with Arranta Bio ("Arranta") for the acquisition of a 29,000 ft2 process development and GMP clinical manufacturing fac... |
| Mar 8, 2021 | Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing | |
| Oct 30, 2019 | Newly launched startup Arranta Bio secures $82M in new funding to provide contract development and manufacturing organization (CDMO) for microbiome pioneers | Arranta Bio, a tech startup launched this year to provide contract development and manufacturing services to pioneering innovators working on new therapies targeting diseases linked to the human microbiome, has closed $82 million funding ro... |
| Oct 30, 2019 | Arranta Bio Raises $82M in Funding | Arranta Bio, a Watertown, MA-based microbiome contract development and manufacturing organization (CDMO), completed an $82m funding round. The round was completed with sole institutional investor Ampersand Capital Partners, company founders... |
| Oct 30, 2019 | Arranta Bio Announces $82M In New Funding | Arranta Bio announced today the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific. Formed in May 2019, Arranta's goal is to be the best-in-class microbiome contract development and manufact... |
| Oct 30, 2019 | Arranta Bio Announces $82M In New Funding | Arranta Bio announced today the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific. Formed in May 2019, Arranta's goal is to be the best-in-class microbiome contract development and manufact... |
Reviews 0
FAQ about Arranta Bio
When was Arranta Bio founded?
Arranta Bio was founded in 2019.
How much funding has Arranta Bio raised?
Arranta Bio has raised $82M in total across 1 funding round.
What has the press written about Arranta Bio?
Parsers VC has collected 10 articles mentioning Arranta Bio, among them “From Fighting Shoplifting To Pioneering Gene Therapies, The Startups In This Accelerator Are On The Front Lines Of “Super Creativity”” (Nov 20, 2022) and “Recipharm completes US biologics acquisitions” (Apr 11, 2022).
Is Arranta Bio still active?
Yes, Arranta Bio is active; its latest activity on Parsers VC dates from Mar 9, 2023.